Oregano and Basil Leaves and Coronary Artery Disease
Launched by SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES · Aug 8, 2025
Trial Information
Current as of August 20, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at whether eating more oregano and basil leaves can help people who have recently experienced unstable angina, a condition where the heart doesn’t get enough blood and oxygen. The study will see if these herbs, which contain natural substances called polyphenols, can reduce inflammation and improve cholesterol levels in the blood. Researchers will also measure the amount of these substances in the urine to understand how the body processes them.
To join this study, you must have been diagnosed with unstable angina, but people with certain other heart attacks, serious liver or kidney problems, autoimmune diseases, or those who are pregnant or breastfeeding cannot take part. While the trial is not yet recruiting participants, those who join will be asked to include oregano and basil leaves in their diet, and the researchers will monitor their blood and urine to see if there are any health benefits. This study aims to find simple, natural ways to support heart health after unstable angina.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients diagnosed with unstable angina
- Exclusion Criteria:
- • Patients diagnosed with STEMI
- • Patients undergoing coronary artery bypass grafting
- • Liver cirrhosis and advanced chronic kidney disease (CKD 5)
- • Having known inflammatory and autoimmune diseases, such as inflammatory bowel disease (IBD) and rheumatoid arthritis, or taking glucocorticoid medications
- • Pregnancy or breastfeeding
About Shahid Beheshti University Of Medical Sciences
Shahid Beheshti University of Medical Sciences, located in Tehran, Iran, is a leading institution dedicated to advancing healthcare through innovative research and education. Renowned for its commitment to medical excellence, the university actively sponsors clinical trials aimed at improving patient outcomes and enhancing medical practices. With a multidisciplinary approach, it collaborates with healthcare professionals and researchers to explore new treatments and interventions, contributing significantly to the global body of medical knowledge. The institution is dedicated to upholding the highest ethical standards in research, ensuring the safety and well-being of participants while fostering a culture of scientific inquiry and discovery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tehran, , Iran, Islamic Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported